By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


SEARCH JOBS








Company News
Upsher-Smith Laboratories Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes 10/23/2014 9:21:53 AM
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014 8:22:53 AM
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014 9:44:32 AM
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014 8:46:43 AM
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014 8:52:44 AM
Upsher-Smith Laboratories Release: Qudexy™ XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia 6/17/2014 10:30:04 AM
Upsher-Smith Laboratories Named Healthcare Distribution Management Association's Manufacturer Partner Of The Year 6/10/2014 9:35:23 AM
Upsher-Smith Laboratories Receives Final NDA Approval For Vogelxo™ (Testosterone) Gel CIII 6/5/2014 8:36:56 AM
New Data From Upsher-Smith Laboratories's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy of Neurology 4/21/2014 10:36:19 AM
Upsher-Smith Laboratories Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules 3/13/2014 6:26:32 AM
12345678910...
//-->